NEJM paper buoys GW Pharma as it eyes FDA filing for cannabis drug Epidiolex

GW Pharma's cannabis-based epilepsy treatment Epidiolex is firmly on track for a filing in the U.S. after new data published in the New England ...

read more here
Delivered by @can_nab_is